Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Nat Med. 2022 Oct 17;28(11):2424–2435. doi: 10.1038/s41591-022-02023-7

Extended Data Fig. 3. Transcriptionally (mRNA+) and transcriptionally + translationally (mRNA+p24+) active HIV-1-infected cells following ART initiation.

Extended Data Fig. 3

Changes in HIV-1-infected cells during the first 30 days of ART among the four groups shown as median (error bars represents interquartile ranges) number of CD3+CD8− T cells expressing either HIV-1 mRNA (a) or HIV-1 mRNA and Gag p24 protein (b). ART-control n=4, ART+3BNC117 n=5, ART+RMD n=4, ART+3BNC117+RMD n=5.

ART, antiretroviral therapy; RMD, romidepsin.